Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW679769 for Chemotherapy-Induced Nausea and Vomiting
NCT00169572Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 19
01
Overview
Phase 2, randomised, double-blind trial of casopitant in chemotherapy-induced nausea and vomiting (CINV) (3 arms), sponsored by GSK. Primary endpoint: The number of subjects who do not experience vomiting, retching or nausea at 5 days. Started Feb 2005; status: completed.
02
Drugs
casopitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00169572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169572.